Abstract
A newly established cell line, designated NRS-1, was derived from an alveolar rhabdomyosarcoma that developed in the left forearm of a 7-year-old girl. The cell line had a t(2; 13) chromosomal translocation. Reverse transcription-polymerase chain reaction demonstrated that 5′ PAX3-3′ FKHR chimeric transcript was expressed in NRS-1 cells. NRS-1 cells showed myogenic differentiation without any particular stimulus in vitro and exhibited various kinds of muscle markers. All-trans retinoic acid promoted cell differentiation in the myogenic direction. Transforming growth factor-β (TGF-β) inhibited myogenic differentiation of those cells and promoted cell proliferation.
Similar content being viewed by others
References
Clayton J, Pincott JR, van den Berghe JA, Kemshead JT (1986) Comparative studies between a new human rhabdomyosarcoma cell line, JR-1 and its tumour of origin. Br J Cancer 54: 83–90
Crouch GD, Helman LJ (1991) All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines. Cancer Res 51: 4882–4887
Douglass EC, Valentine M, Etcubanas E, Parham D, Webber BL, Houghton PJ, Green AA (1987) A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 45: 148–155
Enzinger FM, Weiss SW (1988) Soft tissue tumors. Mosby, St Louis
Gabbert HM, Gerharz CD, Engers R, Muller-Kliser W, Moll R (1988) Terminally differentiated postmitotic tumor cells in a rat rhabdomyosarcoma cell line. Virchows Arch [B] 55: 255–261
Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher FJ III, Emanuel BS, Rovera G, Barr FG (1993) Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nature Genet 5: 230–235
Garvin AJ, Stanley WS, Bennett DD, Sullivan JL, Sens DA (1986) The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line. Am J Pathol 125: 208–217
Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710–1715
Gerharz CD, Gabbert HE, Biesalski HK, Engers R, Luley C (1989) Fetal calf serum and retinoic acid affect proliferation and terminal differentiation of a rat rhabdomyosarcoma cell line (BA-HAN-1C). Br J Cancer 59: 61–67
Gerharz CD, Gabbert HE, Engers R, Ramp U, Mayer H, Luley C (1989) Heterogeneous response to differentiation induction with different polar compounds in a clonal rat rhabdomyosarcoma cell line (BA-HAN-1C). Br J Cancer 60: 578–584
Hays DM (1993) Rhabdomyosarcoma. Clin Orthop 289: 36–49
Hazelton BJ, Houghton JA, Parham DM, Douglass EC, Torrance PM, Holt H, Houghton P (1987) Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma. Cancer Res 47: 4501–4507
Hosoi H, Sugimoto T, Hayashi Y, Inaba T, Horii Y, Morioka H, Fushiki S, Hamazaki M, Sawada T (1992) Differential expression of myogenic regulatory genes, myodl and myogenin, in human rhabdomyosarcoma sublines. Int J Cancer 50: 977–983
Ignotz RA, Massagué J (1985) Type β transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc Natl Acad Sci USA 82: 8530–8534
Kelland LR, Bingle L, Edwards S, Steel GG (1989) High intrinsic radiosensitivity of a newly established and characterised human embryonal rhabdomyosarcoma cell line. Br J Cancer 59: 160–164
Konigsberg IR (1963) Clonal analysis of myogenesis. Science 140: 1273–1284
Kubo K, Naoe T, Utumi KR, Ishiguro Y, Ueda K, Shiku H, Yamada K (1991) Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM. Br J Cancer 63: 879–884
Larco JHD, Todaro GJ (1978) Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75: 4001–4005
Lollini P-L, De Giovanni C, Re CD, Landuzzi L, Nicoletti G, Prodi G, Scotlandi K, Nanni P (1989) Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs. Cancer Res 49: 3631–3636
Massagué J (1983) Epidermal growth factor-like transforming growth factor. J Biol Chem 258: 13606–13613
Massagué J, Cheifets S, Endo T, Nadal-Ginard B (1986) Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci USA 83: 8206–8210
McCune BK, Patterson K, Chandra RS, Kapur S, Sporn MB, Tsokos M (1993) Expression of transforming growth factor-β isoforms in small round cell tumors of childhood. Am J Pathol 142: 49–59
Moses HL, Yang EY, Pietenpol JA (1990) TGFβ stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 62: 245–247
Motoyama T, Watanabe H, Yamamoto T (1986) Embryonal rhabdomyosarcoma in nude mice and in vitro. Acta Pathol Jpn 36: 1495–1505
Motoyama T, Watanabe H, Watanabe T, Yamamoto T (1989) Experimental chemotherapy and radiotherapy to paratesticular rhabdomyosarcoma. J Urol 141: 187–189
Nadal-Ginard B (1978) Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell 15: 855–864
Nanni P, Schiaffino S, De Givanni C, Nicoletti G, Prodi G, Del Re B, Eusebi V, Ceccarelli C, Saggin L, Lollini PL (1986) RMZ: a new cell line from a human alveolar rhabdomyosarcoma. In vitro expression of embryonic myosin. Br J Cancer 54: 1009–1014
Ralston SH (1994) Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9: 883–890
Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB (1985) Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 82: 119–123
Shapiro DN, Sublett JE, Li B, Downing JR, Naeve CW (1993) Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53: 5108–5112
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ogose, A., Motoyama, T., Watanabe, H. et al. In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line. Vichows Archiv A Pathol Anat 426, 385–391 (1995). https://doi.org/10.1007/BF00191348
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00191348